These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15518050)

  • 1. Myasthenia gravis.
    Vincent A; Rothwell P
    Autoimmunity; 2004 Jun; 37(4):317-9. PubMed ID: 15518050
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-MuSK antibodies in a case of ocular myasthenia gravis.
    Bennett DL; Mills KR; Riordan-Eva P; Barnes PR; Rose MR
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):564-5. PubMed ID: 16543546
    [No Abstract]   [Full Text] [Related]  

  • 3. MuSK-antibody positive myasthenia gravis: questions from the clinic.
    Sanders DB; Juel VC
    J Neuroimmunol; 2008 Sep; 201-202():85-9. PubMed ID: 18684517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mantle cell lymphoma and anti-MuSK-positive Myasthenia gravis.
    Bhatt A; Farooq MU; Chang HT
    Onkologie; 2011; 34(7):382-3. PubMed ID: 21734425
    [No Abstract]   [Full Text] [Related]  

  • 6. Bread-and-butter in diagnosis of myasthenia gravis.
    Chan AY; Liu DT
    Arch Neurol; 2005 Dec; 62(12):1939; author reply 1939-40. PubMed ID: 16344357
    [No Abstract]   [Full Text] [Related]  

  • 7. [Seronegative myasthenia gravis].
    Catar O; Aubé-Nathier AC; Nadaj-Pakleza A
    Med Sci (Paris); 2017 Nov; 33 Hors série n°1():34-38. PubMed ID: 29139384
    [No Abstract]   [Full Text] [Related]  

  • 8. Dyspnoea due to vocal fold abduction paresis in anti-MuSK myasthenia gravis.
    Sylva M; van der Kooi AJ; Grolman W
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1083-4. PubMed ID: 18708570
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
    Hain B; Hanisch F; Deschauer M
    Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Advances in Autoimmune Myasthenia Gravis.
    Punga AR; Kusner L; Berrih-Aknin S; Le Panse R
    Front Immunol; 2020; 11():1688. PubMed ID: 32983085
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MG with distal muscle involvement.
    Iwasaki Y; Igarashi O; Kawabe K; Kiyozuka T; Kawase Y; Aoyagi J; Iwasa Y; Hirano K; Satoh R; Ikeda K
    Acta Neurol Scand; 2004 Oct; 110(4):270; author reply 271-2. PubMed ID: 15355493
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of disease-specific autoantibodies in seronegative myasthenia gravis.
    Bartoccioni E; Marino M; Evoli A; Ruegg MA; Scuderi F; Provenzano C
    Ann N Y Acad Sci; 2003 Sep; 998():356-8. PubMed ID: 14592896
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies.
    Andreetta F; Rinaldi E; Bartoccioni E; Riviera AP; Bazzigaluppi E; Fazio R; Deiana G; Pini A; Giudizi MG; Baggi F
    Neurol Sci; 2017 Oct; 38(Suppl 2):253-257. PubMed ID: 29030770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prepubertal anti-Musk positive myasthenia gravis with long remission.
    Gungor-Tuncer O; Orhan EK; Yilmaz V; Parman Y; Oflazer P; Saruhan-Direskeneli G; Deymeer F
    Neuromuscul Disord; 2014 Jan; 24(1):36-9. PubMed ID: 24074501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vocal cord paralysis as a manifestation of myasthenia gravis with anti-MuSK antibodies.
    Jiménez Caballero PE; Fermin Marrero JA; Trigo Bragado I; Casado Naranjo I
    Neurologia; 2014 May; 29(4):253-4. PubMed ID: 23040717
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-MuSK positivity on plasmapheresis liquid in a double seronegative myasthenia gravis patient.
    Renard D; Candon S; Jacob M; Trusson R; Reboul P
    Acta Neurol Belg; 2018 Mar; 118(1):119-120. PubMed ID: 28608313
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.